We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Origin Bancorp
OBK
$1.66B
| $1.94M | ﹤0.01% |
87,933
+12,016
| +16% | +$246K |
|
2352
Pacific Biosciences
PACB
$370M
| $1.94M | ﹤0.01% |
560,956
-12,128
| -2% | -$41.3K |
|
2353
Spyre Therapeutics
SYRE
$9.25B
| $1.93M | ﹤0.01% |
8,336
+4,792
| +135% | +$913K |
|
2354
TechnipFMC
FTI
$27.3B
| $1.93M | ﹤0.01% |
378,349
+44,517
| +13% | +$259K |
|
2355
Q32 Bio
QTTB
$464M
| $1.92M | ﹤0.01% |
7,030
+1,851
| +36% | +$493K |
|
2356
DMC Global
BOOM
$157M
| $1.92M | ﹤0.01% |
69,409
+1,921
| +3% | +$53K |
|
|
CCRD
2357
DELISTED
CoreCard
CCRD
| $1.91M | ﹤0.01% |
56,053
-33,637
| -38% | -$1.13M |
|
|
BCEL
2358
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $1.9M | ﹤0.01% |
89,232
-49,465
| -36% | -$874K |
|
2359
Digi International
DGII
$3.1B
| $1.89M | ﹤0.01% |
162,013
+183
| +0.1% | +$1.96K |
|
|
HONE
2360
DELISTED
HarborOne Bancorp
HONE
| $1.88M | ﹤0.01% |
219,784
+86,196
| +65% | +$689K |
|
2361
Amalgamated Financial
AMAL
$1.49B
| $1.88M | ﹤0.01% |
148,291
+5,461
| +4% | +$57.9K |
|
|
MTSC
2362
DELISTED
MTS Systems Corp
MTSC
| $1.88M | ﹤0.01% |
106,613
+24,917
| +30% | +$461K |
|
2363
Cars.com
CARS
$660M
| $1.87M | ﹤0.01% |
324,871
+46,342
| +17% | +$256K |
|
2364
American Vanguard Corp
AVD
$68.9M
| $1.87M | ﹤0.01% |
135,837
-26,022
| -16% | -$349K |
|
|
MSGN
2365
DELISTED
MSG Networks Inc.
MSGN
| $1.87M | ﹤0.01% |
187,854
-7,742
| -4% | -$88.4K |
|
|
FLIC
2366
DELISTED
First of Long Island Corp
FLIC
| $1.86M | ﹤0.01% |
113,640
-2,924
| -3% | -$44.8K |
|
2367
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
| $1.85M | ﹤0.01% |
322,200
+15,000
| +5% | +$70K |
|
|
ABTX
2368
DELISTED
Allegiance Bancshares
ABTX
| $1.85M | ﹤0.01% |
72,754
-2,955
| -4% | -$72.5K |
|
2369
Tredegar Corp
TG
$310M
| $1.84M | ﹤0.01% |
119,758
+16,553
| +16% | +$256K |
|
2370
Biglari Holdings Class B
BH
$1.21B
| $1.84M | ﹤0.01% |
26,694
+6,483
| +32% | +$417K |
|
2371
BRC Group Holdings
RILY
$289M
| $1.84M | ﹤0.01% |
84,616
+7,935
| +10% | +$152K |
|
2372
Hawkins
HWKN
$2.71B
| $1.84M | ﹤0.01% |
86,260
+10,560
| +14% | +$200K |
|
2373
Krystal Biotech
KRYS
$9.66B
| $1.83M | ﹤0.01% |
44,200
+2,524
| +6% | +$121K |
|
2374
Regis Corp
RGS
$70.2M
| $1.82M | ﹤0.01% |
11,150
| – | – |
|
2375
Ocular Therapeutix
OCUL
$2.02B
| $1.82M | ﹤0.01% |
218,234
+76,485
| +54% | +$507K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.